CRISPR Medicine (@crisprmedicine) 's Twitter Profile
CRISPR Medicine

@crisprmedicine

We write about CRISPR Medicine โ€“ the reagents, delivery methods, safety, quality control, clinical trials, standards and best practices...

ID: 1189826406676602880

linkhttps://crisprmedicinenews.com calendar_today31-10-2019 08:49:54

1,1K Tweet

2,2K Followers

276 Following

CRISPR Medicine (@crisprmedicine) 's Twitter Profile Photo

๐๐ž๐š๐ฆ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐‚๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐๐ซ๐จ๐จ๐Ÿ-๐Ž๐Ÿ-๐‚๐จ๐ง๐œ๐ž๐ฉ๐ญ ๐ƒ๐š๐ญ๐š ๐ข๐ง ๐€๐ฅ๐ฉ๐ก๐š-1 ๐€๐ง๐ญ๐ข๐ญ๐ซ๐ฒ๐ฉ๐ฌ๐ข๐ง ๐ƒ๐ž๐Ÿ๐ข๐œ๐ข๐ž๐ง๐œ๐ฒ ๐“๐ซ๐ข๐š๐ฅ Beam Therapeutics has announced positive initial data from itsย Phase 1/2 clinical trial of BEAM-302

๐๐ž๐š๐ฆ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐‚๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐๐ซ๐จ๐จ๐Ÿ-๐Ž๐Ÿ-๐‚๐จ๐ง๐œ๐ž๐ฉ๐ญ ๐ƒ๐š๐ญ๐š ๐ข๐ง ๐€๐ฅ๐ฉ๐ก๐š-1 ๐€๐ง๐ญ๐ข๐ญ๐ซ๐ฒ๐ฉ๐ฌ๐ข๐ง ๐ƒ๐ž๐Ÿ๐ข๐œ๐ข๐ž๐ง๐œ๐ฒ ๐“๐ซ๐ข๐š๐ฅ

Beam Therapeutics has announced positive initial data from itsย Phase 1/2 clinical trial of BEAM-302